SG/CALL/PFIZER INC/40/0.1/20.09.24 Stock

Warrant

DE000SQ80BX5

Delayed Deutsche Boerse AG 06:04:02 2024-06-03 EDT
0.001 EUR 0.00% Intraday chart for SG/CALL/PFIZER INC/40/0.1/20.09.24
1 month-75.00%
3 months-83.33%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-03 0.001 0.00%
24-05-31 0.001 0.00%
24-05-30 0.001 0.00%
24-05-29 0.001 0.00%
24-05-28 0.001 -66.67%

Delayed Quote Deutsche Boerse AG

Last update June 03, 2024 at 06:04 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SQ80BX
ISINDE000SQ80BX5
Date issued 2023-02-13
Strike 40 $
Maturity 2024-09-20 (110 Days)
Parity 10 : 1
Emission price 0.75
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.78
Lowest since issue 0.001
Delta0.05x
Omega 13.16
Premium39.96x
Gearing251.96x
Moneyness 0.7165
Difference Strike 11.34 $
Difference Strike %+28.35%
Spread 0.019
Spread %95.00%
Intrinsic value 0.000000

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.66 USD
Average target price
31.92 USD
Spread / Average Target
+11.36%
Consensus